Sort
261,768 grants matching “gene therapy”
LICI Microbiome and Genetics Core
$1,264,977Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Predictive drivers of new onset, relapse, and progression of human autoimmunity in skin
$1,264,957John E Harris · Univ Of Massachusetts Med Sch Worcester · U01 · FY2023 · AI
WU-MDACC Inter-Institutional Molecular Imaging Center
$1,264,315Samuel Achilefu · Washington University · P50 · FY2014 · CA
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells
$1,264,180Stella T Chou · Children'S Hosp Of Philadelphia · U01 · FY2022 · HL
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells
$1,264,180Stella T Chou · Children'S Hosp Of Philadelphia · U01 · FY2020 · HL
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells
$1,264,180Stella T Chou · Children'S Hosp Of Philadelphia · U01 · FY2019 · HL
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells
$1,264,180Stella T Chou · Children'S Hosp Of Philadelphia · U01 · FY2021 · HL
Asymmetric nucleosome substrates to advance the study of the histone code
$1,264,176Marcus Cheek · Epicypher, Inc. · R44 · FY2025 · GM
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,264,156Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2021 · HL
Stem cells for therapeutics discovery in genetic blood disorders
$1,264,005George Q Daley · Boston Children'S Hospital · U01 · FY2018 · HL
Molecular and Cellular Therapies for Muscular Dystrophy
$1,263,930Stanley C Froehner · University Of Washington · P01 · FY2010 · NS
Molecular diagnosis and outcome prediction in lymphoma
$1,263,868Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Oncogenic mechanisms and molecular targets in lymphoma
$1,263,868Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Oncogenic mechanisms and molecular targets in myeloma
$1,263,868Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Basic Research Support for the CCR
$1,263,819Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer
$1,263,739Mitch A Phelps · Ohio State University · R01 · FY2025 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,263,691Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,263,633Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Research Center for Pharmacology and Drug Toxicology
$1,263,595Vanderbilt University · P50 · FY2005 · GM
Role of mouse microbiome in cancer and inflammation
$1,263,350Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
NF Center: from animal models to therapeutics
$1,263,336Luis F Parada · Ut Southwestern Medical Center · P50 · FY2012 · NS
Developing Cone-Dominant Retinal Disease Models as a Resource for Translational Vision Research
$1,263,162Joseph Carroll · Medical College Of Wisconsin · U24 · FY2021 · EY
Overcoming Immune Barriers to Gene Correction for Duchenne Muscular Dystrophy
$1,262,994Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2013 · HD
Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis
$1,262,972Hans-Willem E Snoeck · Columbia University Health Sciences · U01 · FY2022 · HL
Novel mechanisms of NSAID action in Alzheimer disease
$1,262,697Edward H. Koo · University Of California, San Diego · P01 · FY2006 · AG